Cydar Medical today announced the successful treatment of the first patient in a strategic collaboration with Medtronic
(NYSE: MDT)
.
The collaboration spans 40 sites across the U.S., UK and Europe, integrating the Cydar Maps software with Medtronic services and case support. The collaboration aims to improve patient care and efficiency with AI-based solutions placed into the clinical environment.
Cydar and Medtronic entered into the collaboration in April 2022. The company also has a strategic partnership with Philips.
Dr. George Pontikis treated the first patient in the pilot program at Edward Hospital in Illinois. He said the technology helped to navigate complex vascular procedures with greater precision.
UK-based Cydar developed its Cydar Maps platform to transform the dissemination of information to clinicians in image-guided minimally invasive surgery. The company designed it to simplify complexities within operating theaters across the globe.
Cydar’s platform generates a 3D map of patient soft tissue. It supports and integrate pre-operative planning, intra-operative guidance and post-operative review of endovascular surgery. The platform utilizes AI to update the map throughout the patient journey.
According to the company, benefits include halved radiation exposure, simplified workflows and increased clinician confidence. Cydar said the program should also inform the ongoing development of its platform to include predictive analytics.
“This is an important milestone for Cydar, to be working with Medtronic to accelerate the adoption of our AI solution by the global endovascular community,” said Paul Mussenden, CEO of Cydar. “The goal is to provide clinicians with a more predictable and efficient way to perform minimally invasive image-guided procedures.
“We look forward to supporting the treatment of additional patients across the planned 40 sites and to continue the introduction of the exciting product developments we have planned over the course of the year ahead.”